NCT06650956 Integration to Improve Adolescent Health and HPV Vaccination in Laos
| NCT ID | NCT06650956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Health Poverty Action |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2024-11-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to find out if adding HPV vaccination to adolescent health services works to increase HPV vaccine uptake in 10-13-year-old girls in Laos. The study will also look at the effects of adding HPV vaccination on the use of other health services in 10-13-year-old boys and girls. The main questions the study aims to answer are: 1. Does adding HPV vaccination to adolescent health services increase HPV vaccine uptake in girls aged 10-13 years compared to girls who only receive standard HPV vaccination services? 2. Does adding HPV vaccination to adolescent health services increase the use of other health services in 10-13-year-old adolescent boys and girls compared to adolescents who only receive standard HPV vaccination services? 3. What are the barriers and facilitators to using the combined intervention in Laos? 4. What are the opinions of adolescents, caregivers, healthcare providers, and other stakeholders on the combined intervention? 5. How much does it cost and how well it works to combine HPV vaccination with adolescent health services, as opposed to providing HPV vaccination alone? Researchers will compare a combined intervention to standard HPV vaccination services to see if the combined intervention works to increase HPV vaccination uptake and the use of other health services. The combined intervention includes HPV vaccination given at schools, health facilities, and through community outreach. It also includes education on sexual and reproductive health, counseling, and other health services. Participants in the combined intervention group will: 1. Receive the HPV vaccine at school or at a health facility. 2. Take part in group discussions about sexual and reproductive health. 3. Take part in individual counseling sessions. 4. Use other health services as needed. Participants in the comparison group will receive standard HPV vaccination services, including: • HPV vaccination given at schools, health facilities, and through community outreach.
Eligibility Criteria
Inclusion Criteria: * Female aged 10-13 years for HPV vaccination and SRH education * Male aged 10-13 years for SRH education * 10-13-year-old male and female students in randomly selected schools with at least 100 students in target classes (year-5 primary, year-1, 2 and 3 secondary) * 10-13-year-old males and females who are out-of-school and living in 2 remote villages each from four randomly selected health centers located around the selected schools Exclusion Criteria: * males and females younger than 10 years or older than 13 years
Contact & Investigator
Thet Lynn, MD, MMedSc Global Health
PRINCIPAL INVESTIGATOR
Health Poverty Action
Frequently Asked Questions
Who can join the NCT06650956 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 13 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06650956 currently recruiting?
Yes, NCT06650956 is actively recruiting participants. Contact the research team at kchaluenvong@gmail.com for enrollment information.
Where is the NCT06650956 trial being conducted?
This trial is being conducted at Muang Sing, Laos.
Who is sponsoring the NCT06650956 clinical trial?
NCT06650956 is sponsored by Health Poverty Action. The principal investigator is Thet Lynn, MD, MMedSc Global Health at Health Poverty Action. The trial plans to enroll 700 participants.